Lucia Zamorano, MD, PLC

Brain & Spine Surgery

MICHIGAN BRAIN & SPINE

SURGERY CENTER

  • Phone: (248) 723-2477 | Fax: (248) 681-3209
  •   New Patient Forms »  
  •   Leave Feedback »     Review Us »  
Menu
  • Home
  • About
    • About Dr. Zamorano
    • Testimonials
    • Practice Members
    • Published Articles
    • Community Events
    • Press
    • Close
  • Specialties
    • Auto & Workman’s Compensation
    • Brain & Spine Tumors
    • Cervical Spine Surgery
    • Computer Assisted Surgery
    • Endoscopic Spine Surgery
    • Endoscopy Brain
    • Endoscopic Lumbar Fusion
    • Endoscopy Spine
    • Epilepsy Surgery
    • Gamma Knife
    • Intra-Operative MRI
    • Kyphoplasty
    • Laser Surgery
    • Low Grade Gliomas
    • Lumbar Spine Surgery
    • Minimally Invasive Surgery
    • Movement Disorders
    • Neurosurgical Oncology
    • Pain Management
    • Pituitary Tumors
    • Radio Surgery
    • Robotic Surgery
    • Robotics Endoscopic Spine Surgery
    • Skull Base Surgery
    • Spinal Cord Injury
    • Spine Surgery
    • StemWave Therapy
    • Stereotactic Surgery
    • Traumatic Brain Injury
    • Trigeminal Neuralgia
    • Close
  • Forms
    • New Patient Information
    • Medication Protocol
    • Close
  • Patient Education
    • Category Index
    • Educational Articles
    • Hospital Links
    • Health Library
    • Innovative Technologies
    • Close
  • Blog
  • Locations
  • Careers
  • Contact Us
    • VIP Concierge Program
    • Close
    • Close
You are here: Home / Archives for Alzheimer

Link Between Concussions and Alzheimer’s Disease

Researchers find link between concussions and Alzheimer’s disease

Boston University School of Medicine

New research has found concussions accelerate Alzheimer’s disease–related brain atrophy and cognitive decline in people who are at genetic risk for the condition. The findings, which appeared in the journal Brain, show promise for detecting the influence of concussion on neurodegeneration.

Moderate–to–severe traumatic brain injury is one of the strongest environmental risk factors for developing neurodegenerative diseases such as late–onset Alzheimer’s disease, although it is unclear whether mild traumatic brain injury or concussion also increases this risk.… [Continue Reading]

Filed Under: Alzheimer Disease Tagged With: Alzheimer, Alzheimer's Disease

Deep Brain Stimulation: New Hope For Alzheimer?

alzheimersAlzheimer’s disease (AD) could be the next frontier for deep brain stimulation (DBS) therapy.

A small phase 1 pilot study showed that some patients with AD who received constant stimulation to the fornix — the principle outflow tract from the hippocampus — had increased hippocampal volume after 1 year.

There was also some evidence that this increased hippocampal volume correlated with cognitive benefit.

… [Continue Reading]

Filed Under: Alzheimer Tagged With: Alzheimer

Alzheimer’s Gene Effects May Show Up in Infancy

infancyInfants and toddlers with the Alzheimer’s disease-associated APOE4 genotype already showed distinctive patterns of brain structure relative to other young children, researchers said.

MRI scans carried out in 60 normally developing children, age 2 to 25 months, who carried the APOE epsilon-4 allele, showed smaller volumes of gray matter and and lower white matter myelin water fraction (MWF) compared with 102 children in the same age range whose APOE genes only include the epsilon-2 and/or epsilon-3 alleles, according to Sean C. L. Deoni, PhD, of Brown University in Providence, R.I., and colleagues.

“While our findings should be considered preliminary, this study demonstrates some of the earliest brain changes associated with the major genetic risk factor for late-onset Alzheimer’s disease,” the researchers wrote online in JAMA Neurology.

… [Continue Reading]

Filed Under: Alzheimer Tagged With: Alzheimer

Peanut Butter and Alzheimer?

peanut-butter“Could a scoop of peanut butter and a ruler become that elusive test?”

If you treat the elderly, or any member of the growing number of families devastated by Alzheimer’s disease, you may be asked some version of that question, as posed by CBS News, in the coming weeks. You can thank media coverage of a study in the Oct. 15 issue of the Journal of Neurological Sciences titled “A Brief Olfactory Test for Alzheimer’s Disease.”

Here’s that brief olfactory test, as the CBS headline suggests: “A container of 14 g of peanut butter was opened, held medially at the bottom of a 30 cm ruler, and moved up 1 cm at a time during the participants’ exhale. Upon odor detection, the distance between the subject’s nostril and container was measured.”

… [Continue Reading]

Filed Under: Alzheimer Tagged With: Alzheimer

Concussions cause brain abnormalities similar to Alzheimer’s

brainMore and more research has raised concern over the dangers of concussions – one of the most common forms of head trauma – as many sufferers go on to experience persistent neurological symptoms throughout their lives.

Now, scientists have discovered a clue as to why mild traumatic brain injuries (MTBI) can have such long-lasting health consequences.

In a study published in the journal Radiology, researchers found that white matter damage in the brains of people who had experienced concussions closely resembled the type of white matter damage found in patients with Alzheimer’s disease.  These findings suggest that concussions set off a chain of neurological events that can cause long-term damage to the brain.

“It’s not the hitting your head that’s the problem.  It’s everything else that happens after that,” said lead study author Dr. Saeed Fakhran, assistant professor of radiology in the Division of Neuroradiology at the University of Pittsburgh School of Medicine.

… [Continue Reading]

Filed Under: Concussion Tagged With: Alzheimer, Concussion

MRI May Tell Alzheimer’s from Other Dementias

MRI of BrainThree-fourths of patients with Alzheimer’s disease or frontal-lobe degeneration had MRI-detected biomarker levels that correlated with the diagnoses, suggesting MRI has potential as a screening tool for the conditions, investigators reported.

MRI-predicted values for total tau and β-amyloid ratio (tt/Aβ) in gray matter correctly pinpointed the diagnosis in 75% of patients with genetically or neuropathologically confirmed diagnoses, according to Corey McMillan, PhD, of the University of Pennsylvania in Philadelphia, and colleagues. Predicted values also had good correlation with actual tt/Aβ measured in cerebrospinal fluid (CSF), they said.

The findings are consistent with previous in vivo and autopsy studies of CSF tt/Aβ, the group reported in the Jan. 8 issue of Neurology.

… [Continue Reading]

Filed Under: Alzheimer Tagged With: Alzheimer, Alzheimer disease, Dementia

Inflammation as a New Therapeutic Approach For Alzheimer’s Disease

Inflammation as a New Therapeutic Approach For Alzheimer’s DiseaseIn the next several decades the number of Alzheimer’s patients will continue to dramatically increase. Various teams of researchers worldwide are feverishly investigating precisely how the illness develops.
Inflammation as a New Therapeutic Approach For Alzheimer’s Disease

A team of scientists under the guidance of the University of Bonn and University of Massachusetts (USA) and with the participation of the German Center for Neurodegenerative Diseases have discovered a new signaling pathway in mice which is involved in the development of chronic inflammation which causes nerve cells in the brain to malfunction and die off. The results are now being published in the renowned scientific journal “Nature”.

… [Continue Reading]

Filed Under: Alzheimer Tagged With: Alzheimer, Alzheimer disease, Inflammation

Second Bapineuzumab Trial Fails in Alzheimer’s

Pauline Anderson

A second phase 3 trial investigating bapineuzumab IV in patients with mild to moderate Alzheimer’s disease (AD) has been stopped, essentially spelling the end of the program to investigate this agent in patients with this type of dementia.

The 18-month, randomized, double-blind, multicenter studies were examining the efficacy and safety of bapineuzumab, a monoclonal antibody that targets beta-amyloid (Aß), in patients who carry the apolipoprotein E epsilon 4 (ApoE4) genotype and in those who do not.… [Continue Reading]

Filed Under: Alzheimer Tagged With: Alzheimer, Bapineuzumab

Ceramides in Blood May Signal Alzheimer’s Disease Risk

High levels of a family of lipids called ceramides in the blood may be predictive of developing Alzheimer’s disease, a new study suggests.

Women with the highest levels of ceramides had a 10-fold higher risk of developing Alzheimer’s compared with those with the lowest levels, said Michelle M. Mielke, PhD, from the Mayo Clinic, Rochester, Minnesota.

“The study is small — that’s a limitation, and it was a preliminary study. However, given the small sample size, to have hazard ratios that are near 10 was quite striking and we didn’t expect to see that at all,” Dr. Mielke told Medscape Medical News.… [Continue Reading]

Filed Under: Alzheimer Tagged With: Alzheimer, ceramides

Bapineuzumab Fails in Phase 3 Alzheimer’s Trial

Pfizer Inc has announced topline results of a phase 3 trial of bapineuzumab showing treatment failed to meet the co-primary endpoint of change in cognitive or functional performance versus placebo in patients with mild to moderate Alzheimer’s disease (AD) who are positive for the apolipoprotein E4 (ApoE4) risk allele.

Bapineuzumab is an investigational monoclonal antibody that targets amyloid-ß (Aß) under development by the Alzheimer’s Immunotherapy Program (AIP), a partnership between Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI) and Pfizer Inc.… [Continue Reading]

Filed Under: Alzheimer Tagged With: Alzheimer, Bapineuzumab

  • 1
  • 2
  • Next Page »

Popular Topics

Alzheimer Alzheimer's Disease Alzheimer disease alzheimers atrial fibrillation Bapineuzumab Brain Cancer brain disorder Brain Tumor breast cancer Cancer cell phones coffee Community Support Concussion CPAP DBS Dementia depression ECT epilepsy Epilepsy Surgery Glioblastoma Glioblastoma Multiforme headache Headache Disorders Medical Marijuana memory sleep Metastasis migraine Minimally Invasive Surgery opioid Pain Pain Management Parkinson’s Disease Preoperative MRI sleep apnea sleep disorders stroke TBI TDCS TIA TMS Traumatic Brain Injury VNS

Topic Articles

  • ACE Inhibitors
  • Alzheimer
  • Alzheimer Disease
  • Amnesia and Memory
  • Aneurysm
  • Aneurysms
  • ARB's
  • Arrythmia
  • Artificial Disc Replacement
  • Botox
  • Brain
  • Brain Cancer
  • Brain Hemorrhage
  • Brain Metastasis
  • Brain Stimulation
  • Brain Surgery
  • Brain Tumors
  • Cancer
  • Cervical Stenosis
  • Cognition
  • Community Events
  • Concussion
  • CPAP
  • Dementia
  • Depression
  • Disc Replacement
  • Dizziness
  • Drug Overdose
  • Endoscopic Spine Surgery
  • Epidural
  • Epilepsy
  • Fibromyalgia
  • Glioblastoma Multiforme
  • Gliomas
  • Guidelines
  • Hand Tremors
  • Headache
  • Low Grade Gliomas
  • Lumbar Disc
  • Malignant Astrocytoma
  • Malignant Gliomas
  • Medical Marijuana
  • Memory
  • Migraine
  • Mild Cognitive Impairment
  • Neuromodulation
  • Neurostimulation
  • News
  • Osteoporosis
  • Pain
  • Pain Management
  • PTSD
  • Robotics
  • SI-BONE
  • Sleep Apnea
  • Spinal Cord Injury
  • Spine Robotics
  • Spine Surgery
  • Stem Cells
  • Stroke
  • Tinnitus
  • Traumatic Brain Injury

Visit Our

Health Library

Clinical Expertise

  • Auto & Workman’s Compensation
  • Brain & Spine Tumors
  • Cervical Spine Surgery
  • Computer Assisted Surgery
  • Endoscopic Lumbar Fusion
  • Endoscopic Spine Surgery
  • Endoscopy Brain
  • Endoscopy Spine
  • Epilepsy Surgery
  • Gamma Knife
  • Intra-Operative MRI
  • Kyphoplasty
  • Laser Surgery
  • Low Grade Gliomas
  • Lumbar Spine Surgery
  • Minimally Invasive Surgery
  • Movement Disorders
  • Neurosurgical Oncology
  • Pain Management
  • Pituitary Tumors
  • Radio Surgery
  • Robotic Surgery
  • Robotics Endoscopic Spine Surgery
  • Skull Base Surgery
  • Spinal Cord Injury
  • Spine Surgery
  • StemWave Non-Invasive Acoustic Wave Therapy Machine
  • Stereotactic Surgery
  • Traumatic Brain Injury
  • Trigeminal Neuralgia

VIP/Concierge Program

We offer immediate patient scheduling 24/7. Our VIP/Concierge Services Program offers a full array of services for the discerning patients and families as well as out of town or international patients and families. Learn more.

Languages Spoken

Spanish, German, French, Portuguese, Italian, Chaldean, Arabic and English.

Connect With Us

  • Email
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Locations

Troy
5107 Rochester Rd., Troy, MI 48085
Hours: Mon-Fri: 9:00 am - 5:00 pm
Birmingham
2004 Hazel St., Birmingham, MI 48009
Hours: Mon-Fri: 9:00 am - 5:00 pm
Physical Therapy & Rehabilitation
5107 Rochester Rd., Troy, MI 48085
Hours: Mon - Fri: 8:00am-5:00pm

Contact Information

Phone: (248) 723-2477
Fax: (248) 681-3209 or (248) 481-3913
eFax: (248) 671-0621
  • View Our Locations
  • Michigan Brain & Spine Surgery Center
  • Physical Therapy and Rehabilitation
  • LinkedIn Page

Copyright © 2025 Michigan Brain & Spine Surgery Center. Lucia Zamorano, MD. PLC.
All Rights Reserved · Disclaimer · Privacy Policy